Showing posts with label BioMarine Business Convention 2012. Show all posts
Showing posts with label BioMarine Business Convention 2012. Show all posts

Tuesday, 22 January 2013

BioMarine in International Aquafeed magazine

The BioMarine Business Convention 2012 features in the new issue of International Aquafeed magazine.

The event is shown into the spotlight with a 16-page supplement including proceedings from the six Think Tanks and debates.

Read the full report online here or the view the whole issue online here.

International Aquafeed January/February 2013

Enhanced by Zemanta

Friday, 16 November 2012

BioMarine Business Convention final report online

The final report from the BioMarine Business Convention is now available online. The report includes the proceedings from the five think tanks and a round. Invaluable to those who were there, interesting for those who weren't. Download the report and view photos from the convention here.

Tuesday, 23 October 2012

Tick, tick, tick, counting down to BioMarine

The BioMarine Business Convention kicks off tomorrow so I thought I'd share this interview with chairman Pierre Erwes. Pierre gives us the lowdown on what promises to be a great event.  The article also features the convention's main sponsors. Click on the image to read the article or click here.
Click here to read the article

Monday, 22 October 2012

Thalocea Profile

Thalocea develops market intelligence tools in the sector of marine bio resources and marine renewable energies.  Since the beginning Thalocea and BioMarine have established a strong relationship to provide the industry with accurate strategic information. This year again, Thalocea is actively contributing to Biomarine.  To optimise your participation to the BioMarine business convention and the one to one partnership, Thalocea has prepared this company profile.  We look forward to actively working with you in London.
Enhanced by Zemanta

Friday, 19 October 2012

Novus Profile

Take a Closer Look at Novus Aquaculture
Novus creates animal and nutrition solution based on science. Grounded in lab research and tested in practical field studies, Novus products have long provided innovative solutions for the poultry, swine, dairy, beef and aqua industries. Over 2,500 clients in nearly 100 countries trust Novus to be an integral part of their daily animal agriculture operations.
Now that tradition of innovation continues with solutions for aquaculture. Novus monitors the evolving needs of the industry on a daily basis. Novus understands its many pressures, for which the talented researchers and developers are continuously working to create solutions. Driven by customer feedback, this team is focused on providing the industry with sustainable and cost-efficient solutions. Novus is dedicated to anticipating today what the industry will need tomorrow.
Aquaculture will soon become the world’s leading source of animal protein, providing wholesome nutrition to an ever-growing population. To produce the food that’s needed in a profitable, sustainable manner, the industry faces many significant challenges. Now and in the future, the industry can count on Novus as their partner in overcoming these challenges.
Click on the image to visit the Novus website

Novus: Investing in the Future of Aquaculture
Novus is committed to making Aquaculture production more efficient and profitable. The Novus staff, which includes nearly 80 research and development experts, dedicates itself to this mission every day. And by supporting graduate scholarships at leading aquaculture research institutions worldwide, Novus is also investing in the future of the industry.
Novus’s goal is to provide innovative total management solutions that optimize aquaculture production. Novus is dedicated to providing customized solutions that enhance the health and performance of your animals.
To learn more about our aquaculture solutions, contact your local Novus Sales Representative or Novus Customer Service. Outside of the U.S., call +1.314.576.8886, within the U.S., call 1.800.568.0088 or send an e-mail to aqua@novusint.com.
Enhanced by Zemanta

Olmix Profile

Founded in 1995 by Hervé Balusson, Olmix Group was born at the core of Brittany, in Bréhan (Morbihan) from the will to find natural alternatives to additives used in agriculture.
Its business is specially based on the development of natural additives based on seaweeds, trace-elements and clays towards Animal and Vegetal Nutrition and Health.
With its famous Amadéite®, 100% natural biomaterial, Olmix has become one of the worldwide main specialists of green tech. One of the first green refineries in the world, the ULVANS Project, will soon be established in Brittany (France), and will industrially process products from algae. 
For 15 years, Olmix is involved in algae valorisation, and its philosophy is based on the belief that they are the new “Green Gold”. Olmix logo is by the way built with algae, more than a symbol, for a better life!
Click on the image to visit the Olmix website
Olmix is present in 60 countries throughout the world, has 250 employees and makes a turnover of 53,4 million Euros, of which 80 % of sales exported. Listed on the Paris Stock Exchange, Olmix has 7 production sites in Europe and its natural innovations lead the group to become a main reference in sustainable development with significant growth perspectives. Olmix Group’s strategy is in phase with regulations and environmental evolutions in the world.
Enhanced by Zemanta

Thursday, 11 October 2012

Sofiproteol Profile

Sofiprotéol was formed in 1983 at the initiative of the French federation of oilseed and protein crop producers : the Fop, the ONIDOL and UNIP. Originally a financial establishment for the French vegetable oil and protein subsidiary, Proléa, Sofiprotéol’s investments and acquisitions have made it a major agri-food group in France today. 

Sofiprotéol relies on an original economic model characterised by:
  • a solid base of agricultural shareholders, representing each region of France,
  • an active presence in every aspect of the industry,
  • a strong commitment in the field of sustainable development. 
Sofiprotéol’s mission is to develop the French vegetable oil and protein industry, open up new markets, and ensure an equal distribution of value among its members. 

In order to succeed in its mission, Sofiprotéol is involved in every aspect of the industry: 
  • research,
  • marketing,
  • processing,
  • adding value to products.
The Group’s strategy involves maintaining a balanced presence in key fields related to nutrition and the environment:
  • human and animal nutrition,
  • renewable energy and renewable chemistry development.
     

Monday, 8 October 2012

MG4U profile

With the BioMarine Business Convention less than three weeks away, we'll be taking a closer look at the main sponsors and partners.

First up is MG4U...

The EU coordination action Marine Genomics 4 Users (MG4U) responds to several critical bottlenecks. It spreads results from recent and on-going projects in marine genomics and enhances rapid, efficient knowledge transfer to generate interdisciplinary research capacity in Europe. Cutting-edge genomic approaches are now sufficiently mature to advance the knowledge based bio-economy in the marine sector. Marine genomics has enormous potential to improve our lifestyles and prosperity, and to assist with governance and sustainable management of the marine environment.

Today, marine genomics knowledge is a vital part of “blue biotechnology”, and is leading to applications in the management of natural and cultured resources, and preserving marine environments. However, many business leaders and legislators are not yet aware of how marine genomics hold great potential for problem solving and industrial commercial advantage. Valuable knowledge is made accessible and disseminated in user-friendly contexts by Marine Genomics for Users (MG4U). We facilitate knowledge and technology transfer between high-throughput marine genomics, industry and society through dedicated sessions, workshops, face-to-face contacts and access to a knowledge output database.

The EU project Micro B3 on marine microbial Biodiversity, Bioinformatics, and Biotechnology will develop innovative bioinformatic approaches and a legal framework to make large-scale data on marine viral, bacterial, archaeal and protists genomes and metagenomes accessible for marine ecosystems biology and to define new targets for biotechnological applications. Micro B3 will build upon a highly interdisciplinary consortium of 32 academic and industrial partners.

Micro B3 is based on a strong user- and data basis from ongoing European sampling campaigns to long-term ecological research sites. For the first time a strong link between oceanographic and molecular microbial research will be established to integrate global marine data with research on microbial biodiversity and functions. The Micro B3 Information System will provide innovative open source software for data-processing, -integration, -visualisation, and -accessibility. Interoperability will be the key for seamless data transfer of sequence and contextual data to public repositories.

Micro B3 will allow taking full advantage of current sequencing technologies to efficiently exploit large-scale sequence data in an environmental context. Micro B3 will create integrated knowledge to inform marine ecosystems biology and modeling. Moreover, it will facilitate detecting candidate genes to be explored by targeted laboratory experiments for biotechnology and for assigning potential functions to unknown genes. Micro B3 will develop clear IP agreements for the protection and sustainable use of pre-competitive microbial genetic resources and their exploitation in high potential commercial applications.

More information...
Enhanced by Zemanta

Monday, 1 October 2012

Exclusive interview with Pierre Erwes of the BioMarine Business Convention

Our sister publication, International Aquafeed magazine talks exclusively to Pierre Erwes, founder of the BioMarine Business Convention.  Here Pierre tells us what's happening this year and why the BioMarine movement is expanding so rapidly.  View the magazine online for free here.

Monday, 10 September 2012

BioMarine Participants: Pierre Calleja, Fermentalg

Pierre Calleja Chairman, CEO and Founder of Fermentalg, France
A biologist by training, Pierre Calleja began his career at the Ifremer research institute where his work centered on the development of larval breeding techniques in marine farms.
He then went on to create Kurios (a subsidiary of Sanofi Aquaculture) in 1992 where he developed an innovative range of larval feed and fish feed nutritional supplements designed to optimize breeding techniques. By 1999, Kurios’s revenues has doubled year-on-year to stand at €4 million, with exports accounting for 80% of the company’s sales. In 2000, Pierre Calleja sold Kurios to the global leader in larval fish nutrition, INVE.
From 2000 to 2005, Pierre Calleja worked in collaboration with Ifremer research institute on an R&D project for the mass production of microalgae under heterotrophic conditions.
In 2005, he acquired Aquatyca (specialized in aquariology fish feed) which he went on to sell in 2008.
In 2007, Pierre Calleja filed two patents linked to the farming of microalgae which led to the creation of Fermentalg in 2009.  More information...

Pierre Calleja

Enhanced by Zemanta

Thursday, 30 August 2012

Interview: Helena Vieira, CEO Bioalvo

Hello, 
Today we are pleased to have a new interview from one of the participants at the BioMarine Business Convention.  Helena Vieira is the CEO of Bioalvo, a biotech company for natural products.  Here she tells us about the company and its forthcoming role at BioMarine.

What is BIOALVO?
Bioalvo, the Biotech for Natural Products, is a Portuguese start-up company with a privileged access to the biggest continental platform in Europe – Portugal’s.

Bioalvo develops fully integrated biotech solutions to maximize natural products market applications in areas as diverse as cosmetics, household products, nutraceuticals, pharmaceuticals or even industrial.

Bioalvo holds unique and proprietary microorganisms natural extracts collections form the unique Portuguese deep Ocean (PharmaBUG, LUSOMAREXTRACT) and Land (LUSOEXTRACT) ecosystems and couples these assets with its unique and patented discovery technology GPS D2, its extensive assay development and HTS robotics capacity as well as production and full development capacities in house, providing its partners with a one-stop-shop solution for their innovation in natural product development. By using Bioalvo’s organization as a fully integrated or modular partner in the different stages of a novel ingredient development our partners are bringing a natural product solution closer and quicker to market. In the last year Bioalvo has identified and is developing novel and innovative ingredients such as a new marine botox-like ingredients with topical action for pharmaceutical and cosmetical applications, novel marine natural anti-UV protectors for cosmetic and textile applications and novel marine neuroprotective and anti-inflammatories compounds with tremendous potential for several other applications. Mostly, at Bioalvo we thrive to find sustainable and natural solutions in the Portuguese ocean and ecosystems to solve current society problems, making everyone’s life healthier, better and more natural. In 2011 the company was awarded the highest national prize for biodiversity and sustainability (BES BIODIVERSIDADE 2011) and was ranked at the TOP 6 best companies in Europe’s Most Innovative Biotech SME Award 2011.

You have a unique business model, could you elaborate on your development strategy?
“It’s not the strongest or the fittest that survive but the most adaptable”(Charles Darwin). In a world were society is evermore demanding and conscious and where the biotech innovation model is under strain on multiple fronts this conclusion by Charles Darwin couldn’t be more appropriate to what BIOALVO has done. Portugal has always been connected to the sea by geographical and historical reasons, but is not yet a major player in the biotech arena. In recent years the ocean has been in the spotlight as a key source of untapped bioactives, derived both from marine macro and microorganisms. However, a sustainable and profitable screening and production of innovative bioactives is essential for the success in incorporating these ingredients into a marketed product and ensuring a sales stream. BIOALVO has become a strong player in this market, offering to its pharmaceutical, cosmetics, household or nutraceutical partners an unprecedented access to one of the world’s richest sources of bioactives: The Portuguese continental shelf and the Mid-Atlantic Rift off Portugal’s Azores islands.

We see a lot of interest and growing activity in the sector of marine microorganisms.
Do you think there is room for new comers?

This is a sector where there is still so much to be developed and discovered, and therefore there is room (and actually the need!) for many players. New markets cannot develop without dynamics, competition and coopetition or if only a couple of players are acting on it. So the more new players will work on marine bacteria, the more this sector is likely to to take off and deliver real useful innovative solutions!

What kind of partnerships are you looking for at BioMarine London 2012?

BIOALVO will be participating in 2 think-thanks, on the women debate and will also make a company presentation and will be available for one-2-one meetings so, we are eager to meet potential partners at the convention and explore mutually beneficial new projects. Come and visit us in BIOMARINE BUSINESS CONVENTION 2012 in London and find out our latest developments and contributions to a better world!

Read the full text here.

You can also find out more about the BioMarine Business Convention, October 24-25, 2012 here.
Enhanced by Zemanta

Friday, 10 August 2012

BioMarine Participants: Olivier Bourtourault

Olivier Bourtourault is the Founder of Aleor, a French SME developing seaweeds culture and processing in Brittany, France. Engineer specialised in Biology, he has studied in France and Japan before creating Aleor in 2007, which developed patented processes for seaweeds off-shore culture and processing. It offers leading quality products and services for the cosmetics and food companies, and also is a partner with energetics and waste management companies.
If you're good at French, check out the Aleor website here.



Thursday, 9 August 2012

Video: Franciso Gomes, Novus

Novus International is one of the main sponsors of the BioMarine Business Convention 2012, to be held in London this October.  In this video, Francisco Gomes, Global Aquaculture Manager, describes the company's solutions for aquaculture agriculture.

Wednesday, 1 August 2012

BioMarine News: Eurofins presentation

Dr. Michael Kühnel, graduated in molecular biology, is Sales Manager at Eurofins GfA Lab Service GmbH, Germany, today's worldwide leading dioxin laboratory.
He is responsible for the GMP services of the analytical laboratory and specially focused on aquaculture customers.
Before joining Eurofins in 2010 he has hold several sales positions in companies focusing on molecular biology, pathology and analytical services for medical device and pharmaceutical companies.


Enhanced by Zemanta

Thursday, 5 July 2012

Confirmed participants at BioMarine Think tanks

Over the next few days we're going to have a look at the participants at the BioMarine business Convention Think tanks.

First up is Dr Mike Allen, Senior Scientist at Plymouth Marine Laboratory.

His interests are varied and encompass both blue skies and applied research topics. Blue skies research focuses mainly on understanding the role of viruses in the ocean using genomic, proteomic, transcriptomic and metabolomic approaches. Applied research focuses on biocatalysis, biotransformation, bioprocessing and technology development.

See his recent publications here.



Enhanced by Zemanta

Wednesday, 4 July 2012

BioMarine Brochure

I am getting more excited as BioMarine Convention draws nearer.  Today I got my hands on the Convention programme.  Take a look below

Thursday, 28 June 2012

Learn more about the BioMarine Business Convention

Roger Gilbert of Perendale Publishers explains a bit more about the BioMarine business Convention.  Watch video...
English: Coral reefs in the Red Sea, near Hurg...
English: Coral reefs in the Red Sea, near Hurghada. (Photo credit: Wikipedia)
Enhanced by Zemanta

Wednesday, 20 June 2012

Grab Early Bird BioMarine tickets before they fly away

Time is running out to grab an early bird discount for the BioMarine Business Convention, October 24-25, 2012, London.

There's just four days left to register for a full ticket for €1,200 (+VAT)

Registration includes:
  • Admission to all presentations, sessions and plenaries
  • Access to BioMarine One to One Business meetings through our partnering system
  • Welcome coffee, morning and afternoon breaks
  • Lunches
  • Networking evening
  • Gala Dinner
  • Participant’s catalogue and final programme both printed and on a USB key
The BioMarine convention will highlight novel and innovative technologies and developments in aquaculture and aquafeed, marine biotechnology, nutraceuticals, algae for feed and nutrition.The program will also feature two debates, six company presentations, and key notes from the UK Ministry of Fisheries, Norway Ministry of Fisheries, Portugal Ministry of Seas, Canada National research Council, DG Mare, DG Sanco, etc.

The dedicated partnering event is designed to provide ample time for face-to-face meetings with the people you want to connect with, from informal networking and discussions with our company presenters and program advisers, to facilitated opportunities for one-on-one scheduled meetings.     

BioMarine is an established event that brings together major players from across the marine bio resources field every year.  Join us for our London Summit to hear the latest advances in marine bio resources technologies and applications and meet the innovative young companies who could grow into major players.


“For this commandment . . . is not . . . beyon...
 (Photo credit: Wikipedia)





Enhanced by Zemanta

Interview: Francisco Gomes, Novus

Francisco Gomes, Executive Manager Aqua Business Unit, Novus International, USA
Francisco Saraiva Gomes leads Aquaculture Business Unit at Novus International. After graduating in Marine Biology in Lisbon, he obtained his doctoral degree at Auburn University, USA and has worked in several positions related to aquaculture and marine biotechnology. 

Novus specialises in health and nutrition micro ingredients and functional technologies including antioxidants, amino acids, enzymes, probiotics, prebiotics and mycotoxin binders. The company focuses in four main platforms: Performance Nutrition; Therapeutic Nutrition; Feed Quality and; Consumer Values.



Why is the aqua market so important in the Novus Strategy?

Last year I had the privilege to address the plenary of the world aquaculture society in Natal, Brazil. There I expressed my view that the aquaculture forecasts are an underestimate. Currently, aquaculture is predicted to increase to 220 mmt of production by 2050, from our current 60 something level today.

These estimates fail to incorporate technology development. Actually they assume that the gains in efficiency in aquaculture will continue to occur at a slower rate than in more sophisticated industries such as poultry. This is a mistake, because aquaculture’s efficiency is increasing every day. 

Moreover, it is inaccurate to assume that aquaculture is comparable to poultry, aquaculture is a new platform for human development. Its applications go way beyond meat production per se. Algae is a good example. Algae culture is in many ways a spinoff of highly tech aquaculture sectors. If agriculture is the platform of land, aquaculture is the platform of water and it is essential for mankind to steer this new platform to fundamental sustainability, socially, environmentally and economically.
Aqua is important for Novus simply because we recognise how important it will be to feed the world.

What are the two majors issues Aquaculture is facing in the horizon 2050?

Aquaculture will face many issues all of them critical from here on to 2050. I say that the sustainability of nutrition and offshore farming are probably two of the biggest ones.

Sustainable nutrition will be a key issue affecting the development of the industry as a whole. To produce all this biomass we need to devise a sustainable sourcing for the raw materials that will be used for feed. 

The fishmeal an oil dependency is perhaps the most significant issue, but surely not the only one. We must not be deaf to the criticism invoked about transferring millions of mt of soy produced on land onto the water. Soy is certainly a solution but will it be the only solution in the long term. 

Alternative proteins must be investigated and algae, single cell protein or insect protein are no longer the science fiction cases they were 10 years ago. Not only, that but it seems more and more likely that feeds will be the preponderant vehicle to prevent disease in aquaculture. 

Without proper health management, there will be no industry. The importance of feed also relates to species and culture systems. We need to learn more about the nutritional requirements of our animals so that we can design feeds that are more efficient, so that they are better absorbed. Conversion of feed is something so paramount to the industry that it affects everything from offshore licensing, to design of recirculated systems, to financial profitability and so on.

Offshore farming is perhaps the other big topic. The potential of the oceans to provide us with food is enormous. I’m convinced that the sustainability of the human species depends on farming the oceans. But the oceans are an extremely sensitive ecological compartment of the planet. We now know that in spite of the gigantic size of the oceans, we have actually been able to change their chemical properties as whole! This is by all measures an incredible fact. 

So now we know how destructive we can really get if we do not pay attention. Should that prevent us from moving forward? I believe it should not. The only real alternative we have is not whether we should farm the oceans but how do we farm the oceans. 

And there again, feeds and sustainable nutrition will have a major role. Salmon farming is the largest marine cage industry in the world. The two main environmental criticisms are one related with feed waste accumulating in the bottom of the oceans and the other related with biosecurity. Aqua feeds are definitely the solution for the first and a major supporting pillar for the second.

Sometimes the industry still falls on the trap of defending its sustainability by engaging in the argument “what we’re doing is the best alternative available so…?”  . Actually, the world does not want to hear that, we are expected to give not the best available but the sustainable one. And if none of what we are using is the sustainable strategy, then we must recognise that somewhere in the world there will be growing voices of dissatisfaction. 

What role does Novus intend to play in the aquaculture strategy horizon 2050?
Our goal is to be the referential provider of health and nutrition technologies in the industry. Size, revenue and profit all matter of course and we do have ambitious goals well before 2050. But I believe our legacy will be complete if in 2050, we could be recognized as one of the silent partners of a truly sustainable industry that in the space of a century went from virtually nothing, to the largest provider of animal protein in the world.

Can you elaborate on the role of Novus in aquaculture as a water platform?
Aquaculture is the water platform. One of the functions of that platform is the production of animal protein. For that production to be efficient animals need health and nutrition. Not only in their feeds but also in their production systems directly. Novus provides the functionality of health and nutrition strategies used throughout the value chain. 

In summary, our role covers the entire value chain of aquaculture production from raw materials to harvest. We do not provide processing plant related technologies. And within that value chain, we focus on five key platforms: Feed Cost Reduction, Functional Feeds, Health through Nutrition, Optimised Raw Materials and Sustainable Practices. We do not provide the feed, the same way we do not provide raw materials or the culture systems. What we do is to optimise such raw materials or processes. 

This role allows us to be at the cornerstone of the development of the industry. Our technologies are hinging points from which the industry can support itself and adapt in one or the other direction. The five key areas we focus on are basically essential for the development of a sustainable industry.

Is this water platform an international strategy for the development of a sustainable aquaculture?

I surely would like to see it that way. Most of the human nutrition in the world is originated from plant and animal species domesticated 10,000 years ago. Very few species were actually added on to our “portfolio” after the agricultural revolution. Aqua is the big exception. 

But it is an exception occurring at a time where our technology and our knowledge of the processes allow us to develop it in a completely different way. Bottom line our technology gives us choices. We can in fact steer aquaculture the best way possible. But for that we need innovation, research and development. And for that we need resources: human, capital, organisational, managerial, social, environmental and many others. 

We do not know what Aqua 2050 will be but we have a pretty good idea that if it will be a sustainable one, it will come by knowledge creation and knowledge sharing.  So my question is what best way to capture resources, organise them and manage them for results, that to recognise a single, diversified yet coherent platform for human development. 

You see, most of our growth is still yet to come. And in order to tap on that richness, we need to have more ambitious innovation. Science requires repetition, but are we not repeating enough already. Could we not have higher compartmentalisation of R&D in aquaculture and have better and more defined strategies and policies of research in aquaculture. I keep getting surprised by how much overlap there is in R&D plans across the world. Not only amongst private companies but also amongst public institutions. I think the development of the Water Platform would allow us – all the members of the industry to organise ourselves better and to better leverage all of our resources better, and fundamentally to progress faster and more sustainably.

This year Novus is actively participating to the 2012 BioMarine summit in London. What are your expectations?

Simply put to learn about companies, technologies, executives priorities and concerns.

What do you expect or what do you see as a practical outcome for your aquaculture Think-tank?

I would like us to come out of that session with a structured document. One that could be published as a three to five year road map and could be considered as an agenda for a more in depth debate and discussion on how to drive marine Aquaculture towards sustainability.

What do you want to say to our BioMarine community and to the attendees of the October summit in London?

First of all, please come by our think tank. Aquaculture is an integrator and we surely benefit from everybody’s contribution, especially if outside the industry. Other than that, I’m really more interested in listening to what the attendees have to say themselves. One of the things I enjoyed about last year’s event was the opportunity to keep a tab on the latest technological and business developments. There is lots and lots of information available to us every day. The problem is not access to information but rather filtering, contextualising it and relating it to your needs. BioMarine is a very good tool for that.

Novus, USA is supporting the up-coming BioMarine Business Convention 2012 in London, UK, form October 24-25, 2012.

Read an extended version of this interview here 

Enhanced by Zemanta

Wednesday, 6 June 2012

Olmix CEO interview

Developing nutritional alternatives from marine resources

Hervé Balusson founded Olmix Group in Brittany, France in 1995. Unusually for the time, Olmix developed natural alternatives to chemical additives used in agriculture. Using high quality trace elements,specific clays and macro-algae, the group created a wide range of natural products to substitute synthesis additives.
Today, Olmix is one of the world’s main specialists in 'green chemistry' and is one of the pioneers of the 'blue biotechnology'.
Olmix has 12 subsidiaries worldwide, is present in 60 countries and employs 250 people. The Breton SME reached a turnover of €53m in 15 years, of which 80 percent was exported sales.
The company is well established in Asia where it achieves a 30 percent growth by year on average. In fact, the ASEAN area represents an increasing share of the group’s turnover.
Olmix Group is listed on the Paris Stock Exchange and has seven production plants in Europe.
The company is the partner of the MacroAlgae Think Tank at the BioMarine Business Convention in October. 
Hervé Balusson, Olmix Group CEO, shares his views on the future of the company and difficulties faced by aquaculture.

After 15 years of algae valorization, what are your observations?
Hervé Balusson (Olmix Group CEO): When I began to get interested in macro-algae, 15 years ago, people believed I was a marginal. However, the sea is unquestionably an amazing source of 'blue biotechnology'. The number of algae species in the world is estimated at almost one million. At the outset of the new millennium, the study of algae is one of the most promising ways to provide answers to mankind issues such as environmental, food and energy challenges. Nature has already the answers to take up these challenges.
Renewable biomasses, algae are rich in proteins, carbohydrates, trace elements and especially in active principles often underestimated.
Algae reflect the company’s philosophy as sustainable solutions: thanks to algae, Olmix is able to provide natural, efficient and universal solutions. By 'universal', I mean that our products have the capacity to adapt to various types of production, in different contexts.
The macro-algae high potential combined with our mastery in sourcing and industrial processes led us to technological breakthrough, to the development of numerous innovations and revolutionary products, particularly by the association of the mineral and the organic.
Our group has the advantage of being able to promptly launch its new technology at competitive prices on the market thanks to our well established international sales team. This territorial anchorage gives company open-mindedness and dynamism.

Aquaculture is today facing some challenges, what solutions do you provide?
HB: Increasing production, fishmeal replacement, high quality products requirement (in compliance with standards and certifications), feed efficiency improvement, pathologies limitation, maintaining water quality … These are the challenges the aquaculture sector is facing today.
Olmix proposes solutions in line with the market concerns and provides a full range of products intended for aquaculture.
Fish meal replacement has for example generated a new problematic, previously unknown, the mycotoxins risk management, linked to recourse to plant origin commodities. MTX+ responds to this new demand by supplying an effective and reliable solution to control this risk.
The innovative nature of our products is intrinsically related to valuation of both nutritional and functional algae properties which ensure effectiveness and originality.
Solutions provided by Olmix are universal and meet the feed millers and farmers needs and are besides the result of a privileged relationship based on our proximity with our different partners.

Is the future of Olmix linked to algae valorization?
HB:The group’s medium and long-term development is indeed predicated on the implementation of a complete sector for macro-algae valorization.
This year we are starting a large-scale project, the 'Industrial Strategic Innovation' program from Oséo called ULVANS, gathering 5 companies (OLMIX, PRP, MELSPRING, AMADEITE, AGRIVAL) and two French academic partners (South Brittany University, National Centre of Scientific Research from Mulhouse).
The aim of the ULVANS project is to create a sea lettuce valorization sector, from the harvesting to the marketing of innovative products destined for the animal and vegetable nutrition and health markets.

Health through algae, a new challenge for Olmix?
HB: Our expertise in the knowledge and the mastering of active principles stemming from macro-algae opened up new fields of application. The group’s Research and Development teams focus today on the valorization of our innovations in the health sector.
The sea must be considered as an infinite reservoir of solutions, it contains the potential to solve major health issues.
'Health through algae' is the founding concept of the new Amadéite company which is developing breakthrough products dedicated to control animal and vegetable pathologies (immunostimulation, anti-infective agents, elicitation effect).